|
|
{{if listFind(vars.channel_names, "MSIF News")}} {{endif}}  {{if listFind(vars.channel_names, "MSIF News")}} {{endif}} {{if listFind(vars.channel_names, "MSIF News")}} 
MSIF News
{{endif}}
|
{{if listFind(vars.channel_names, "People With MS News")}} {{endif}}  {{if listFind(vars.channel_names, "People With MS News")}} {{endif}} {{if listFind(vars.channel_names, "People With MS News")}} 
Profile of the Month
{{endif}}
|
{{if listFind(vars.channel_names, "Research News")}} {{endif}}  {{if listFind(vars.channel_names, "Research News")}} {{endif}} {{if listFind(vars.channel_names, "Research News")}} 
Research News
{{endif}}
|
{{if listFind(vars.channel_names, "MS Society News")}} {{endif}}  {{if listFind(vars.channel_names, "MS Society News")}} {{endif}} {{if listFind(vars.channel_names, "MS Society News")}} 
MS News
{{endif}}
|
|
|
|
Making Connections
|
{{if listFind(vars.channel_names, "MSIF News")}}
|
|
MSIF News
 |
 |
| Summaries of new MSIF activities, events, projects, programmes, resources, publications and more. |
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}
|
|
Profile of the Month
 |
 |
| Summaries of news, views and achievements from people with MS around the world. |
Profile of the Month : October 2008
Kathleen Wilson
 Country: USA Age: 50 Occupation: Founding President, MSWorld, Inc Type of MS: Relapsing remitting Year of diagnosis: 1988
My motto is ‘wellness is a state of mind.’ I believe that living well is a choice that we make every day and our personal happiness has everything to do with how we feel about ourselves and how we connect and share with others.
Read the full article here:
English Espanol Italiano Francais Deutsch Русский
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}
|
|
Research News
 |
 |
| Summaries of all the latest research findings on MS selected by a team based at the Institute of Neurology, London. |
Acute disseminated encephalomyelitis: study of factors involved in a possible development towards multiple sclerosis
The authors studied acute disseminated encephalomyelitis (ADEM), a demyelinating disease which typically occurs in children, and found that 27% of people developed MS afterwards.
authors: Tur C, Téllez N, Rovira A, Tintoré M, Río J, Nos C, Perkal H, Castilló J, Horga A, León A, Galán I, Sastre-Garriga J, Montalbán X
source: Neurologia. 2008 Sep 18. [Epub ahead of print]
read more
CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial
This preliminary study looked at a new intravenous MS treatment. It appeared to be safe and there were no serious side effects but further larger studies are needed to prove whether it is effective in MS.
authors: Viglietta V, Bourcier K, Buckle GJ, Healy B, Weiner HL, Hafler DA, Egorova S, Guttmann CR, Rusche JR, Khoury SJ
source: Neurology. 2008 Sep 16;71(12):917-24
read more
Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation
The authors studied a molecule involved in inflammation found in the spinal fluid. They found that people with MS have higher levels of it and suggested that it could be a target for future treatment.
authors: Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, Rinker J 2nd, Naismith RT, Panina-Bordignon P, Passini N, Galimberti D, Scarpini E, Colonna M, Cross AH
source: Brain. 2008 Sep 12. [Epub ahead of print]
read more
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
This study compared treatment with beta-interferon and glatiramer acetate in people with relapsing-remitting MS. No differences were found between the two treatments.
authors: Mikol DD, Barkhof F, Chang P, Coyle PK, Jeffery DR, Schwid SR, Stubinski B, Uitdehaag BM; on behalf of the REGARD study group
source: Lancet Neurol. 2008 Sep 10. [Epub ahead of print]
read more
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}
|
|
MS News
 |
 |
| Summaries of MS news from websites around the world. |
|
{{endif}}
|
|
Tell a friend

The email you subscribed with us is {{print email}}
Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.
If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.
If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here
Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org
|
|